Cargando…

A Pooled Analysis of Preoperative Inflammatory Biomarkers to Predict 90-Day Outcomes in Patients with an Aneurysmal Subarachnoid Hemorrhage: A Single-Center Retrospective Study

An inflammatory response after an aneurysmal subarachnoid hemorrhage (aSAH) has always been in the spotlight. However, few studies have compared the prognostic impact of inflammatory biomarkers. Moreover, why these inflammatory biomarkers contribute to a poor prognosis is also unclear. We retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Zhaobo, Lin, Fa, Li, Runting, Chen, Xiaolin, Zhao, Yuanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954360/
https://www.ncbi.nlm.nih.gov/pubmed/36831800
http://dx.doi.org/10.3390/brainsci13020257
_version_ 1784894100228538368
author Nie, Zhaobo
Lin, Fa
Li, Runting
Chen, Xiaolin
Zhao, Yuanli
author_facet Nie, Zhaobo
Lin, Fa
Li, Runting
Chen, Xiaolin
Zhao, Yuanli
author_sort Nie, Zhaobo
collection PubMed
description An inflammatory response after an aneurysmal subarachnoid hemorrhage (aSAH) has always been in the spotlight. However, few studies have compared the prognostic impact of inflammatory biomarkers. Moreover, why these inflammatory biomarkers contribute to a poor prognosis is also unclear. We retrospectively reviewed aSAH patients admitted to our institution between January 2015 and December 2020. The 90-day unfavorable functional outcome was defined as a modified Rankin scale (mRS) of ≥ 3. Independent inflammatory biomarker-related risk factors associated with 90-day unfavorable outcomes were derived from a forward stepwise multivariate analysis. Receiver operating characteristic curve analysis was conducted to identify the best cut-off value of inflammatory biomarkers. Then, patients were divided into two groups according to each biomarker’s cut-off value. To eliminate the imbalances in baseline characteristics, propensity score matching (PSM) was carried out to assess the impact of each biomarker on in-hospital complications. A total of 543 patients were enrolled in this study and 96 (17.7%) patients had unfavorable 90-day outcomes. A multivariate analysis showed that the white blood cell (WBC) count, the systemic inflammation response index, the neutrophil count, the neutrophil-to-albumin ratio, the monocyte count, and the monocyte-to-lymphocyte ratio were independently associated with 90-day unfavorable outcomes. The WBC count showed the best predictive ability (area under the curve (AUC) = 0.710, 95% CI = 0.652–0.769, p < 0.001). After PSM, almost all abnormal levels of inflammatory biomarkers were associated with a higher incidence of pneumonia during hospitalization. The WBC count had the strongest association with poor outcomes. Similar to nearly all other inflammatory biomarkers, the cause of poor prognosis may be the higher incidence of in-hospital pneumonia.
format Online
Article
Text
id pubmed-9954360
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99543602023-02-25 A Pooled Analysis of Preoperative Inflammatory Biomarkers to Predict 90-Day Outcomes in Patients with an Aneurysmal Subarachnoid Hemorrhage: A Single-Center Retrospective Study Nie, Zhaobo Lin, Fa Li, Runting Chen, Xiaolin Zhao, Yuanli Brain Sci Article An inflammatory response after an aneurysmal subarachnoid hemorrhage (aSAH) has always been in the spotlight. However, few studies have compared the prognostic impact of inflammatory biomarkers. Moreover, why these inflammatory biomarkers contribute to a poor prognosis is also unclear. We retrospectively reviewed aSAH patients admitted to our institution between January 2015 and December 2020. The 90-day unfavorable functional outcome was defined as a modified Rankin scale (mRS) of ≥ 3. Independent inflammatory biomarker-related risk factors associated with 90-day unfavorable outcomes were derived from a forward stepwise multivariate analysis. Receiver operating characteristic curve analysis was conducted to identify the best cut-off value of inflammatory biomarkers. Then, patients were divided into two groups according to each biomarker’s cut-off value. To eliminate the imbalances in baseline characteristics, propensity score matching (PSM) was carried out to assess the impact of each biomarker on in-hospital complications. A total of 543 patients were enrolled in this study and 96 (17.7%) patients had unfavorable 90-day outcomes. A multivariate analysis showed that the white blood cell (WBC) count, the systemic inflammation response index, the neutrophil count, the neutrophil-to-albumin ratio, the monocyte count, and the monocyte-to-lymphocyte ratio were independently associated with 90-day unfavorable outcomes. The WBC count showed the best predictive ability (area under the curve (AUC) = 0.710, 95% CI = 0.652–0.769, p < 0.001). After PSM, almost all abnormal levels of inflammatory biomarkers were associated with a higher incidence of pneumonia during hospitalization. The WBC count had the strongest association with poor outcomes. Similar to nearly all other inflammatory biomarkers, the cause of poor prognosis may be the higher incidence of in-hospital pneumonia. MDPI 2023-02-02 /pmc/articles/PMC9954360/ /pubmed/36831800 http://dx.doi.org/10.3390/brainsci13020257 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nie, Zhaobo
Lin, Fa
Li, Runting
Chen, Xiaolin
Zhao, Yuanli
A Pooled Analysis of Preoperative Inflammatory Biomarkers to Predict 90-Day Outcomes in Patients with an Aneurysmal Subarachnoid Hemorrhage: A Single-Center Retrospective Study
title A Pooled Analysis of Preoperative Inflammatory Biomarkers to Predict 90-Day Outcomes in Patients with an Aneurysmal Subarachnoid Hemorrhage: A Single-Center Retrospective Study
title_full A Pooled Analysis of Preoperative Inflammatory Biomarkers to Predict 90-Day Outcomes in Patients with an Aneurysmal Subarachnoid Hemorrhage: A Single-Center Retrospective Study
title_fullStr A Pooled Analysis of Preoperative Inflammatory Biomarkers to Predict 90-Day Outcomes in Patients with an Aneurysmal Subarachnoid Hemorrhage: A Single-Center Retrospective Study
title_full_unstemmed A Pooled Analysis of Preoperative Inflammatory Biomarkers to Predict 90-Day Outcomes in Patients with an Aneurysmal Subarachnoid Hemorrhage: A Single-Center Retrospective Study
title_short A Pooled Analysis of Preoperative Inflammatory Biomarkers to Predict 90-Day Outcomes in Patients with an Aneurysmal Subarachnoid Hemorrhage: A Single-Center Retrospective Study
title_sort pooled analysis of preoperative inflammatory biomarkers to predict 90-day outcomes in patients with an aneurysmal subarachnoid hemorrhage: a single-center retrospective study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954360/
https://www.ncbi.nlm.nih.gov/pubmed/36831800
http://dx.doi.org/10.3390/brainsci13020257
work_keys_str_mv AT niezhaobo apooledanalysisofpreoperativeinflammatorybiomarkerstopredict90dayoutcomesinpatientswithananeurysmalsubarachnoidhemorrhageasinglecenterretrospectivestudy
AT linfa apooledanalysisofpreoperativeinflammatorybiomarkerstopredict90dayoutcomesinpatientswithananeurysmalsubarachnoidhemorrhageasinglecenterretrospectivestudy
AT lirunting apooledanalysisofpreoperativeinflammatorybiomarkerstopredict90dayoutcomesinpatientswithananeurysmalsubarachnoidhemorrhageasinglecenterretrospectivestudy
AT chenxiaolin apooledanalysisofpreoperativeinflammatorybiomarkerstopredict90dayoutcomesinpatientswithananeurysmalsubarachnoidhemorrhageasinglecenterretrospectivestudy
AT zhaoyuanli apooledanalysisofpreoperativeinflammatorybiomarkerstopredict90dayoutcomesinpatientswithananeurysmalsubarachnoidhemorrhageasinglecenterretrospectivestudy
AT niezhaobo pooledanalysisofpreoperativeinflammatorybiomarkerstopredict90dayoutcomesinpatientswithananeurysmalsubarachnoidhemorrhageasinglecenterretrospectivestudy
AT linfa pooledanalysisofpreoperativeinflammatorybiomarkerstopredict90dayoutcomesinpatientswithananeurysmalsubarachnoidhemorrhageasinglecenterretrospectivestudy
AT lirunting pooledanalysisofpreoperativeinflammatorybiomarkerstopredict90dayoutcomesinpatientswithananeurysmalsubarachnoidhemorrhageasinglecenterretrospectivestudy
AT chenxiaolin pooledanalysisofpreoperativeinflammatorybiomarkerstopredict90dayoutcomesinpatientswithananeurysmalsubarachnoidhemorrhageasinglecenterretrospectivestudy
AT zhaoyuanli pooledanalysisofpreoperativeinflammatorybiomarkerstopredict90dayoutcomesinpatientswithananeurysmalsubarachnoidhemorrhageasinglecenterretrospectivestudy